US FDA Preparing to Vote on these Potential RSV Vaccines

US FDA Preparing to Vote on these Potential RSV Vaccines

Investors may want to keep an eye on Pfizer (PFE) and GSK (GSK). That’s because a US FDA advisory panel its two-day meeting to discuss dueling respiratory syncytial virus (RSV) vaccines from the two companies.  By Wednesday evening, the panel will have voted on...
This Oversold Solar Stock Could See Brighter Days

This Oversold Solar Stock Could See Brighter Days

The solar industry could see brighter days ahead. In 2018, the market was valued at about $52.5 billion. By 2026, it could reach $223.3 billion.   All thanks to a global push for green energy, and President Biden’s Inflation Reduction Act.  Plus, remember, the U.S....